The database combines data from 6,764 patient samples, covering 18 cancer types and more than 25.8 million single cells.The database combines data from 6,764 patient samples, covering 18 cancer types and more than 25.8 million single cells.
A yearly rise of at least 7.5% in mutated gene copies’ share best predicted cancer progression among patients with unexplained low counts of certain white blood cells.A yearly rise of at least 7.5% in mutated gene copies’ share best predicted cancer progression among patients with unexplained low counts of certain white blood cells.